Russell NH - Search Results

1

Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Daver N, Schlenk RF, Russell NH, Levis MJ. Daver N, et al. Among authors: russell nh. Leukemia. 2019 Feb;33(2):299-312. doi: 10.1038/s41375-018-0357-9. Epub 2019 Jan 16. Leukemia. 2019. PMID: 30651634 Free PMC article. Review.

2

P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.

Pallis M, Turzanski J, Higashi Y, Russell N. Pallis M, et al. Leuk Lymphoma. 2002 Jun;43(6):1221-8. doi: 10.1080/10428190290026277. Leuk Lymphoma. 2002. PMID: 12152989 Review.

3

Resistance to spontaneous apoptosis in acute myeloid leukaemia blasts is associated with p-glycoprotein expression and function, but not with the presence of FLT3 internal tandem duplications.

Pallis M, Turzanski J, Grundy M, Seedhouse C, Russell N. Pallis M, et al. Br J Haematol. 2003 Mar;120(6):1009-16. doi: 10.1046/j.1365-2141.2003.04210.x. Br J Haematol. 2003. PMID: 12648071 Free article.

4

Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications.

Pallis M, Seedhouse C, Grundy M, Russell N. Pallis M, et al. Leuk Res. 2003 Sep;27(9):803-5. doi: 10.1016/s0145-2126(03)00012-2. Leuk Res. 2003. PMID: 12804638

5

The expression of P-glycoprotein in AML cells with FLT3 internal tandem duplications is associated with reduced apoptosis in response to FLT3 inhibitors.

Hunter HM, Pallis M, Seedhouse CH, Grundy M, Gray C, Russell NH. Hunter HM, et al. Among authors: russell nh. Br J Haematol. 2004 Oct;127(1):26-33. doi: 10.1111/j.1365-2141.2004.05145.x. Br J Haematol. 2004. PMID: 15384974 Free article.

6

FLT3-ITD expression levels and their effect on STAT5 in AML with and without NPM mutations.

Seedhouse CH, Pallis M, Grundy M, Shang S, Russell NH. Seedhouse CH, et al. Among authors: russell nh. Br J Haematol. 2009 Dec;147(5):653-61. doi: 10.1111/j.1365-2141.2009.07901.x. Epub 2009 Sep 22. Br J Haematol. 2009. PMID: 19775300 Free article.

7

The FLT3 internal tandem duplication mutation is a secondary target of the aurora B kinase inhibitor AZD1152-HQPA in acute myelogenous leukemia cells.

Grundy M, Seedhouse C, Shang S, Richardson J, Russell N, Pallis M. Grundy M, et al. Mol Cancer Ther. 2010 Mar;9(3):661-72. doi: 10.1158/1535-7163.MCT-09-1144. Epub 2010 Feb 16. Mol Cancer Ther. 2010. PMID: 20159992

8

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.

Cornelissen JJ, Gratwohl A, Schlenk RF, Sierra J, Bornhäuser M, Juliusson G, Råcil Z, Rowe JM, Russell N, Mohty M, Löwenberg B, Socié G, Niederwieser D, Ossenkoppele GJ. Cornelissen JJ, et al. Nat Rev Clin Oncol. 2012 Oct;9(10):579-90. doi: 10.1038/nrclinonc.2012.150. Epub 2012 Sep 4. Nat Rev Clin Oncol. 2012. PMID: 22949046 Review.

9

Distinct poor prognostic subgroups of acute myeloid leukaemia, FLT3-ITD and P-glycoprotein-positive, have contrasting levels of FOXO1.

Seedhouse CH, Mills KI, Ahluwalia S, Grundy M, Shang S, Burnett AK, Russell NH, Pallis M. Seedhouse CH, et al. Among authors: russell nh. Leuk Res. 2014 Jan;38(1):131-7. doi: 10.1016/j.leukres.2013.10.030. Epub 2013 Nov 8. Leuk Res. 2014. PMID: 24268349

10

Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia.

Burnett AK, Russell NH, Hills RK; United Kingdom National Cancer Research Institute Acute Myeloid Leukemia Study Group. Burnett AK, et al. Among authors: russell nh. Blood. 2016 Jul 21;128(3):449-52. doi: 10.1182/blood-2016-04-712091. Epub 2016 Jun 6. Blood. 2016. PMID: 27268085 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page